CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes
2011 · Arthritis Research & Therapy · 51 citations
https://doi.org/10.1186/ar3333
A
Atsumasa Komori
HSBC Holdings(GB)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
214
Papers
6.7K
Citations
44
h-index
112
i10-index
Atsumasa Komori is an academic researcher from HSBC Holdings. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Liver Diseases and Immunity & Hepatitis C virus research. The author has an h-index of 44, co-authored 182 publications.
ORCID: 0000-0002-2607-9381Papers by this author
worksX Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis
2021 · Gastroenterology · 51 citations
https://doi.org/10.1053/j.gastro.2021.02.061
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B
2024 · Journal of Hepatology · 41 citations
https://doi.org/10.1016/j.jhep.2024.08.010
Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II study
2012 · Journal of Gastroenterology · 30 citations
https://doi.org/10.1007/s00535-012-0600-5
Serum amyloid A triggers the mosodium urate -mediated mature interleukin-1β production from human synovial fibroblasts
2012 · Arthritis Research & Therapy · 30 citations
https://doi.org/10.1186/ar3849
Inhibitory effects of the JAK inhibitor CP690,550 on human CD4+ T lymphocyte cytokine production
2011 · BMC Immunology · 27 citations
https://doi.org/10.1186/1471-2172-12-51
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat